Journal of Asthma and Allergy
Volume 15, 2022 - Issue
Open access
133
Views
3
CrossRef citations to date
0
Altmetric
Rapid Communication
Rapid and Continuing Improvements in Nasal Symptoms with Dupilumab in Patients with Severe CRSwNP
Claus Bachert1 Upper Airways Research Laboratory and Department of Otorhinolaryngology, Ghent University, Ghent, Belgium;2 Division of ENT Diseases, CLINTEC, Karolinska Institutet, Stockholm, Sweden;3 International Airway Research Center, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People’s Republic of ChinaCorrespondence[email protected]
https://orcid.org/0000-0003-4742-1665View further author information
Asif H Khan4 Global Medical Affairs, Sanofi, Chilly-Mazarin, France
https://orcid.org/0000-0001-9158-0116View further author information
Claire Hopkins5 Department of Otorhinolaryngology – Head and Neck Surgery, Guy’s and St Thomas’ Hospitals, London, UK
https://orcid.org/0000-0003-3993-1569View further author information
Michael S Blaiss6 Department of Pediatrics, Medical College of Georgia at Augusta University, Augusta, GA, USA
https://orcid.org/0000-0002-0733-9408View further author information
Zachary M Soler7 Department of Otolaryngology – Head and Neck Surgery, Medical University of South Carolina, Charleston, SC, USAView further author information
, Scott Nash8 Medical Affairs, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USAView further author information
, Shahid Siddiqui8 Medical Affairs, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USAView further author information
, Amy Praestgaard9 Department of Biostatistics, Sanofi, Cambridge, MA, USAView further author information
, Yamo Deniz8 Medical Affairs, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USAView further author information
, Paul J Rowe10 Global Medical Affairs, Sanofi, Bridgewater, NJ, USAView further author information
& Juby A Jacob-Nara10 Global Medical Affairs, Sanofi, Bridgewater, NJ, USAView further author information
show all
Pages 557-563
|
Published online: 04 May 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.